Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Interleukin (IL)-4/IL-13 Blockade on the Structure and Function of Cutaneous Sensory Nerves: An Open-label, Single-arm Longitudinal Study With Dupilumab

NCT04520308 is registered in ClinicalTrials.gov with Eric Simpson as lead sponsor.

NCT NCT04520308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04520308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Interleukin (IL)-4/IL-13 Blockade on the Structure and Function of Cutaneous Sensory Nerves: An Open-label, Single-arm Longitudinal Study With Dupilumab
Lead sponsor
Eric Simpson
Phase
Phase 4
Overall status
Unknown status
Start date
September 1, 2020
Completion date
March 31, 2021
Enrollment
45 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ad, atopic dermatitis, eczema